Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: Immuhistochemistry using a new monoclonal antibody

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1763-1768

  Tokunaga, Yukihiko ^a,b   Nakagami, Mikio ^a   Tokuka, Atsuo ^a   Ohsumi, Kiyoshi ^a  

^a Maizuru Kyosai Hospital   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Colorectal cancer; Dihydropyrimidine dehydrogenase; Human; Immunohistochemistry

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2H9 1B; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDOREDUCTASES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 0037862137     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Advanced Colorectal Cancer Meta-analysis Project: modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10: 896-903, 1992.
2. Advanced Colorectal Cancer Meta-analysis Project: Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12: 960-969, 1994.
3. Heggie GD, Sommadossi JP, Cross DS, Huster WJ and Diasio RB: Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res 47: 2203-2206, 1987.
4. Etienne MC, Cheradome S, Fischel JL, Formento P, Dassonville O, Rence N, Schneider M, Thyss A, Demard F and Milano G: Response to fluorouracil dehydrogenase activity. J Clin Oncol 13: 1663-1670, 1995.
5. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB and Danenberg PV: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidine synthetase, and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000.
6. Takenoue T, Kitayama J, Takei Y, Umetani N, Matsuda K, Nita ME, Hatano K, Tsuruo T and Nagawa H: Characterization of dihydropyrimidine dehydrogenase in immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression. Ann Oncol 11: 273-279, 2000.
7. Mcleod HL, Sludden J, Murray GI, Keenen RA, Davidson AI, Park K, Koruth M and Cassidy J: Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77: 461-465, 1998.
8. Okabe H, Arakawa K, Takechi T and Fukushima M: Expression of recombinant human dihydropyrimidine dehydrogenase and its application to the preparation of anti-DPD antibodies for immunochemical detection. Jpn J Cancer Chemother 27: 891-899, 2000.
9. Tokunaga Y, Hosogi H, Kuwahara M, Nakagami M, Tokuka A and Ohsumi K: Prognostic value of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: Immunohistochemistry using a new monoclonal antibody. Gastroenterology 122: A598, 2002.
10. Japanese Research Society for Cancer of Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of Colon, Rectum, and Anus. 5th ed. Tokyo: Kanehara and Co. Ltd., 1994 (Jpn).
11. Bobrow M, Harris TD, Shaughnessy KJ and Litt GJ: Catalyzed reporter deposition, a novel method of signal amplification: Application ot immunoassays. J Immunol Meth 125: 279-284, 1989.
12. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody procedures. J Histochem Cytochem 29: 577-580, 1981.
13. Herman GE and Alfont EA: The taming of immunohistochemistry: The new era of quality control. Biotech & Histochem 66: 194-199, 1991.
14. Fox SB, Moghaddam A, Westweed M, Turley H, Bicknell R, Garter KC and Harris AL: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: and immunohistochemical study. J Pathol 176: 183-190, 1995.
15. Lee TE: Statistical Methods for Survival Data Analysis. 2nd ed. New York: John Wiley & Sons, 1992.
16. Breslow NE and Day NE: Statistical Methods in Cancer Research. Volume II: The Design and Analysis of Cohort Studies. IARC Sci publ: 1-406, 1987.
17. Graf W, Pahlman L, Bergstrom R and Glimelius B: The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer 70: 559-563, 1994.
18. Williams CS and Tuchman M: Correlations of dihydropyrimidine dehydrogenase, thymidine phosphorylase, and thymidine kinase activities in strongly and weakly malignant cultured murine neuroblastoma cells. Int J Cancer 43: 901-904, 1989.
19. Takechi T, Okabe H, Fujioka A, Murakami Y and Fukushima M: Relationship between protein level and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice. Jpn J Cancer Res 89: 1144-1153, 1998.
20. Tokunaga Y, Hosogi H, Hoppou T, Nakagami M, Tokuka A and Ohsumi K: Prognostic value of thymidine phosphorylase/PD-ECGF in advanced colorectal cancer after surgery. Surgery 131: 541-547, 2002.
21. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidine synthetase in tumour sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994.
22. Nitta M, Tominaga O, Nagawa H, Tsuruo T and Muto T: Dihydropyrimidine dehydrogenase but not thymidine synthetase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Hepato-Gastroenterol 45: 2117-2122, 1998.
23. Kitago K, Ichikawa W, Uetake H and Nihei Z: Dihydropyrimidine dehydrogenase expression in gastric cancer using anti-human dehydropyrimidine dehydrogenase monoclonal antibody. Jpn J Cancer Chemotherapy 29: 245-252, 2002.